Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer

BACKGROUND: A previous pivotal Phase III study (NO16966) demonstrated the benefit of the addition of bevacizumab (BV) to oxaliplatin-based regimens in metastatic colorectal cancer (MCRC). Our study evaluated the safety and efficacy of three oxaliplatin-based chemotherapy regimens (FOLFOX4 [intraveno...

全面介紹

Na minha lista:
書目詳細資料
發表在:Onco Targets Ther
Main Authors: Ohhara, Yoshihito, Suenaga, Mitsukuni, Matsusaka, Satoshi, Shinozaki, Eiji, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2015
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354450/
https://ncbi.nlm.nih.gov/pubmed/25767397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S77190
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍